For instance, in NSCLC, treatment with first- and second-generation EGFR tyrosine kinase inhibitors (TKIs) often leads to the development of the EGFR T790M mutation, while third-generation inhibitors subsequently select for the C797S mutation, both of which confer resistance
In recent years, LOX, LOXL1, and LOXL2 have emerged as potential therapeutic targets in a diverse set of diseases characterized by matrix remodeling and ECM deposition, including fibrosis, primary and metastatic cancers 8,9,10,11,12,13,14
Pacing your day is also important
Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT
Unfortunately, glutathione levels decline with age, most specifically due to poor nutrition, stress, and to toxins from the environment
Finally, long-term safety data (beyond 1 year of use) in men are not yet robust